The Eosinophilic Gastrointestinal Diseases Program (EGID) Program is devoted to the comprehensive care and research of children diagnosed with eosinophilic esophagitis (EoE). Located at our Outpatient Center in Lincoln Park, the program serves the growing number of children who suffer from EoE.
We have a dedicated, multidisciplinary team made up of specialists from many different areas. Combining several areas of expertise into every diagnosis ensures that our patients have the most thorough and best care possible. The team includes:
Our team also provides state-of-the-art diagnostic testing including upper endoscopy, allergy blood testing and skin prick testing, as well as several novel experimental non-invasive or minimally-invasive tests. The treatments offered are individualized to the specific needs of the patients.
Treatments for eosinophilic gastrointestinal diseases (EGID) are diets and drugs. The dietary options include:
The drug treatment options include oral steroids and swallowed steroids.
The EGID Program is led by Barry K. Wershil, MD, EGID Program Co-director and Head of the Division of Gastroenterology, Hepatology and Nutrition. The program is also co-directed by Amir F. Kagalwalla, MD.
The other members of the team include:
If you’d like to request an appointment with one of our specialists, call 1.800.543.7362 (1.800.KIDS DOC®).
Your support is vital in helping us continue to make a difference in the lives of patients and families. Lurie Children’s relies on philanthropic funding to enhance its programs, services and research for children. To learn more, please e-mail the Ann & Robert H. Lurie Children’s Hospital of Chicago Foundation at foundation@luriechildrens.org or call 312.227.7500.
